outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,420,26185.82307,3685.2933207,186063.16247,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1790,0.3960209803,0.1421591349,1.1032187063,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4845,4180,0.8847572468,0.5636760463,1.3887327498,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.5572137415,0.072209374,4.2998178306,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.4939176147,0.2084816685,1.1701489724,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17740,0.6726057545,0.4654180992,0.9720260165,1,1
Cancer,Hematologic Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,420,30972.6091,4357.5772103,220145.8444,0,0
Cancer,Hematologic Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4790,1790,0.3916339223,0.1398465423,1.0967531024,1,0
Cancer,Hematologic Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4845,4180,0.8790697867,0.5600697698,1.3797632572,1,0
Cancer,Hematologic Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.552644542,0.0717055667,4.2593065459,1,0
Cancer,Hematologic Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.4890272495,0.2052218023,1.1653130812,1,0
Cancer,Hematologic Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17740,0.6650221139,0.4598168023,0.9618056795,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,420,26012.803351,3677.9150539,183980.85009,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4790,1790,0.3962582481,0.1426542427,1.1007075302,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4845,4180,0.9038771333,0.5863870266,1.3932673049,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,0.5591651361,0.0723067004,4.3241587277,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.4951702869,0.2087592345,1.1745282245,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4845,17740,0.6723243965,0.4602604623,0.9820962936,1,1
Cancer,Hematologic Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,420,30767.220472,4366.958669,216769.13553,0,0
Cancer,Hematologic Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4790,1790,0.3915883294,0.1406700657,1.0900785396,1,0
Cancer,Hematologic Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4845,4180,0.8985274949,0.5838354709,1.382841056,1,0
Cancer,Hematologic Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,0.5549860823,0.0717323209,4.2938740566,1,0
Cancer,Hematologic Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.4903624377,0.2053644001,1.1708714856,1,0
Cancer,Hematologic Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4845,17740,0.6660454773,0.4550901801,0.9747882888,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.956805966,0.544573079,7.0313604114,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,1.1308668789,0.6586459099,1.9416501015,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4864,4229,1.2900469416,1.0313722411,1.6135988978,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.5065803361,0.7396938534,3.0685455861,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2228720041,0.8302781701,1.8011023202,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,1.0119611101,0.8539881723,1.1991562899,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.9567636739,0.5434863499,7.045115441,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4795,1796,1.1296403482,0.6575361033,1.9407106469,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4864,4229,1.287856332,1.0292156826,1.611493062,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.50586318,0.7394939423,3.0664536749,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2220531654,0.8292762137,1.8008643131,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,1.0088512938,0.8504538503,1.1967503381,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,2.0777466592,0.5790900679,7.4548527411,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4795,1796,1.1964381651,0.6961779124,2.0561759538,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4864,4229,1.3562582028,1.0897389436,1.6879605188,1,1
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,1.4781771865,0.7254187415,3.0120641635,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2030616808,0.8161707446,1.7733512472,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9952389593,0.8375515631,1.182614456,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,2.0797988375,0.5789178913,7.47180778,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4795,1796,1.195785126,0.6954695247,2.056024048,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4864,4229,1.3537559104,1.0871876099,1.6856842814,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,1.4772040927,0.7248443444,3.01048349,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2020468829,0.8146721813,1.7736173417,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9919457627,0.8335097185,1.1804978087,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1074,417,1.7539637537,0.6755331952,4.5540158072,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4740,1751,0.8576441558,0.5824174464,1.2629317725,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4647,3983,1.2346024548,1.0180369788,1.4972375789,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1074,1880,0.6345355064,0.3623925745,1.111047348,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7266522305,0.5491491846,0.9615300884,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4647,17285,0.7560077401,0.6470058595,0.883373303,1,1
Cancer,Solid Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1074,417,1.7507185452,0.6721871339,4.5597650862,1,0
Cancer,Solid Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4740,1751,0.853449869,0.5797136909,1.2564420858,1,0
Cancer,Solid Cancer,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4647,3983,1.2309650341,1.0145346077,1.493566512,1,1
Cancer,Solid Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1074,1880,0.6320601673,0.3609540564,1.1067892102,1,0
Cancer,Solid Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7234464014,0.5469370005,0.9569195266,1,1
Cancer,Solid Cancer,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4647,17285,0.7516698488,0.6425358245,0.8793401708,1,1
Cancer,Solid Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1074,417,1.7351135605,0.6682922849,4.5049436241,1,0
Cancer,Solid Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4740,1751,0.8499298734,0.5771973608,1.2515316923,1,0
Cancer,Solid Cancer,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4647,3983,1.2287318413,1.0183955129,1.4825103987,1,1
Cancer,Solid Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1074,1880,0.6377915014,0.3640465399,1.1173791113,1,0
Cancer,Solid Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7294872202,0.5508841165,0.965995549,1,1
Cancer,Solid Cancer,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4647,17285,0.7581261693,0.64675049,0.8886816438,1,1
Cancer,Solid Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1074,417,1.7196149848,0.6604000982,4.4777032953,1,0
Cancer,Solid Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4740,1751,0.8402184356,0.5709235163,1.2365351917,1,0
Cancer,Solid Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4647,3983,1.2198573119,1.0106433819,1.4723807508,1,1
Cancer,Solid Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1074,1880,0.6370515039,0.3634854257,1.1165086409,1,0
Cancer,Solid Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7278160894,0.5496184233,0.9637891262,1,1
Cancer,Solid Cancer,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4647,17285,0.7548744628,0.6429791839,0.8862424615,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,1077,420,18992.145494,9010.2209682,40032.491073,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4771,1785,1.1264839904,0.5656889209,2.2432226153,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,4735,4105,1.1372717104,0.8962139819,1.4431675575,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1895,0.5440378065,0.2398151142,1.2341888285,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.9927470884,0.6133419657,1.6068471368,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4735,17568,0.8494786254,0.697732442,1.0342272935,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1077,420,22628.526976,10734.930409,47699.445979,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4771,1785,1.1218787683,0.5633376509,2.2342053094,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4735,4105,1.1342918108,0.8935472321,1.4398991634,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1895,0.5422896712,0.2390806041,1.230037412,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.9889681235,0.611091726,1.6005092323,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4735,17568,0.8450420747,0.6935012661,1.0296969061,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1077,420,18865.418574,8945.5065704,39785.786885,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4771,1785,1.1267726733,0.5667786331,2.2400573752,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4735,4105,1.1500311912,0.9139052721,1.4471650194,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1077,1895,0.5461339876,0.2406296676,1.2395077276,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.9960514086,0.6146509461,1.6141167842,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4735,17568,0.8490641597,0.6936378869,1.0393174319,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1077,420,22295.904882,10573.806167,47013.096954,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4771,1785,1.1136685758,0.5610588087,2.2105663034,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4735,4105,1.1405429801,0.9062915634,1.4353419385,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1077,1895,0.545964854,0.2405284686,1.2392612965,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.9950071537,0.6137236531,1.6131678012,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4735,17568,0.8455233071,0.6895282964,1.0368097534,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,13615.292745,2941.978584,63010.722629,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4773,1785,1.3375796374,0.6439653608,2.7782849752,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,4764,4126,1.2242556996,0.9603250916,1.5607235832,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1899,0.8413248361,0.1653216309,4.2815176458,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.9776725854,0.6250288039,1.529279416,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8472317812,0.6911023129,1.0386330326,1,0
Cardiac disease,Conduction Block,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1082,421,16358.942355,3545.2938567,75484.573574,0,0
Cardiac disease,Conduction Block,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4773,1785,1.3329185244,0.6426526064,2.7645912816,1,0
Cardiac disease,Conduction Block,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4764,4126,1.2182022609,0.9543453497,1.5550101951,1,0
Cardiac disease,Conduction Block,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1899,0.8418779053,0.1655906596,4.2801834908,1,0
Cardiac disease,Conduction Block,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.9753586881,0.6243422461,1.5237228882,1,0
Cardiac disease,Conduction Block,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8393996689,0.6826453845,1.0321490778,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1082,421,13745.191566,2973.8893351,63529.697943,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4773,1785,1.3504735,0.6519149142,2.7975716378,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4764,4126,1.2456634352,0.9865164784,1.5728854284,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1082,1899,0.8382664446,0.1645758495,4.2697068503,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.974530776,0.6218779599,1.5271649658,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8425473978,0.6837166404,1.0382753258,1,0
Cardiac disease,Conduction Block,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1082,421,16424.838578,3568.6844693,75595.173694,0,0
Cardiac disease,Conduction Block,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4773,1785,1.3381142554,0.6483317862,2.7617799999,1,0
Cardiac disease,Conduction Block,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4764,4126,1.2335129938,0.9761061196,1.5588000888,1,0
Cardiac disease,Conduction Block,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1082,1899,0.8402450546,0.1650570857,4.2773792397,1,0
Cardiac disease,Conduction Block,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.9737052884,0.6214574511,1.5256104615,1,0
Cardiac disease,Conduction Block,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8357573336,0.6757555992,1.0336434082,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,421,51862.401265,18624.812248,144415.34385,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4785,1791,1.3837430664,0.466606717,4.1035518862,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,4820,4186,0.7881332599,0.5722911009,1.0853812586,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1900,2.9221587523,0.7989089988,10.688340958,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.8976528982,0.4373983739,1.8422124402,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4820,17702,0.7002159028,0.53473764,0.9169025591,1,1
Cardiac disease,Myocardial infarction,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1080,421,61664.429644,22198.49012,171295.51887,0,0
Cardiac disease,Myocardial infarction,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4785,1791,1.37570227,0.4644132821,4.0751563508,1,0
Cardiac disease,Myocardial infarction,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4820,4186,0.7849146099,0.5696347591,1.0815543381,1,0
Cardiac disease,Myocardial infarction,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1900,2.9123927921,0.7958408611,10.657949586,1,0
Cardiac disease,Myocardial infarction,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.8926830645,0.4357850114,1.8286151035,1,0
Cardiac disease,Myocardial infarction,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4820,17702,0.6947171641,0.52974407,0.9110662401,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1080,421,55054.528656,19805.882814,153035.3963,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4785,1791,1.4638388427,0.4926490293,4.3495958174,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4820,4186,0.8731820183,0.635708292,1.1993658832,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1080,1900,2.8913696877,0.7891525042,10.593666783,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.8890468859,0.4343910735,1.819568618,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4820,17702,0.681712923,0.516794834,0.8992592009,1,1
Cardiac disease,Myocardial infarction,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1080,421,67004.336718,24233.319896,185264.79897,0,0
Cardiac disease,Myocardial infarction,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4785,1791,1.4492379658,0.4877042832,4.3064839773,1,0
Cardiac disease,Myocardial infarction,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4820,4186,0.8734386295,0.6350344781,1.2013442827,1,0
Cardiac disease,Myocardial infarction,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1080,1900,2.8881149413,0.7869560173,10.599331768,1,0
Cardiac disease,Myocardial infarction,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.8860467648,0.4344457345,1.8070815457,1,0
Cardiac disease,Myocardial infarction,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4820,17702,0.674313652,0.5091201793,0.8931072067,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.5667046581,0.7442343443,3.2981056363,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.9690306471,0.7746300311,1.212217907,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.8843000668,0.8038088167,0.9728514938,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.8048214709,0.5349778793,1.2107745482,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.8031415735,0.6939423778,0.9295244212,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7564011952,0.7000614956,0.8172750134,1,1
Infection,Hospitalized infection,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.5514681395,0.7366452032,3.267588491,1,0
Infection,Hospitalized infection,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.9604080246,0.7674598979,1.2018654998,1,0
Infection,Hospitalized infection,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4864,4229,0.8793540027,0.7988119913,0.9680168431,1,1
Infection,Hospitalized infection,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.7984791594,0.5305947625,1.2016118762,1,0
Infection,Hospitalized infection,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.7952993411,0.6871047447,0.920530744,1,1
Infection,Hospitalized infection,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7497393471,0.6933457355,0.8107197604,1,1
Infection,Hospitalized infection,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,1.6999615624,0.8069625793,3.5811689263,1,0
Infection,Hospitalized infection,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4795,1796,1.0515950896,0.8398551845,1.3167177543,1,0
Infection,Hospitalized infection,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4864,4229,0.9742773412,0.8875605384,1.0694665844,1,0
Infection,Hospitalized infection,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,0.7831444217,0.5209567173,1.17728626,1,0
Infection,Hospitalized infection,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.7828429485,0.6764423925,0.905979709,1,1
Infection,Hospitalized infection,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7288280246,0.673592911,0.7885924582,1,1
Infection,Hospitalized infection,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,1.6827041737,0.7985140494,3.5459530593,1,0
Infection,Hospitalized infection,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4795,1796,1.0412303631,0.8315376711,1.3038022289,1,0
Infection,Hospitalized infection,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4864,4229,0.9665573489,0.8800300132,1.0615923259,1,0
Infection,Hospitalized infection,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,0.7769127429,0.5165793734,1.168442724,1,0
Infection,Hospitalized infection,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.7751146233,0.6695310563,0.8973484853,1,1
Infection,Hospitalized infection,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7228374326,0.6673917367,0.7828894565,1,1
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.2576402687,0.1982663654,7.977445101,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.7771737627,0.4090553002,1.4765706667,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.9224757971,0.6834810485,1.2450405145,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,2.4066786177,0.5345485915,10.835501321,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.5086197408,0.9036742541,2.5185331019,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9327414488,0.7193163405,1.2094909587,1,0
Infection,Opportunistic infection,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.25271818,0.1974169513,7.949179784,1,0
Infection,Opportunistic infection,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.7760275363,0.4086833998,1.4735581074,1,0
Infection,Opportunistic infection,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4864,4229,0.9218077841,0.6824590078,1.2450998245,1,0
Infection,Opportunistic infection,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,2.3982277741,0.5324657767,10.801626523,1,0
Infection,Opportunistic infection,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.5040293034,0.9016617525,2.508816792,1,0
Infection,Opportunistic infection,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.931360458,0.7168769161,1.2100156711,1,0
Infection,Opportunistic infection,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,1.3354607545,0.2106018466,8.4683750665,1,0
Infection,Opportunistic infection,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4795,1796,0.8232164554,0.4340554606,1.5612874253,1,0
Infection,Opportunistic infection,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4864,4229,0.9958139256,0.7485194407,1.3248091105,1,0
Infection,Opportunistic infection,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,2.3510637684,0.5213199856,10.602894568,1,0
Infection,Opportunistic infection,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.4789117757,0.883644055,2.4751822049,1,0
Infection,Opportunistic infection,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9062396024,0.6928378686,1.1853714326,1,0
Infection,Opportunistic infection,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,1.3240295775,0.2090156168,8.3871930194,1,0
Infection,Opportunistic infection,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4795,1796,0.818831059,0.4329211285,1.5487446995,1,0
Infection,Opportunistic infection,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4864,4229,0.9900320476,0.744209233,1.3170536078,1,0
Infection,Opportunistic infection,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,2.3478819323,0.5199907338,10.601245772,1,0
Infection,Opportunistic infection,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.4772790101,0.8821904066,2.4737893966,1,0
Infection,Opportunistic infection,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9071198987,0.691712459,1.1896077625,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1042,407,1.6046014725,0.590766712,4.3583123987,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4596,1734,2.5978645107,1.468482364,4.5958332095,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4515,3966,1.5060405917,1.0828950442,2.0945319456,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0634015904,0.6143715132,1.8406174735,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.504901194,1.1343362045,1.9965223666,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0758934394,0.8442280385,1.3711303584,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1042,407,1.5903334665,0.5855208448,4.3195055431,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4596,1734,2.5782059741,1.457238933,4.5614661361,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4515,3966,1.4997169719,1.0778139978,2.0867710016,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0561885586,0.6103776313,1.8276132905,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.4935897054,1.125927676,1.9813086183,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0680720808,0.8370219434,1.3629009119,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1042,407,1.6880530039,0.6204785283,4.5924601964,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4596,1734,2.7386907369,1.5433896275,4.8597106128,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4515,3966,1.6018599867,1.1554323208,2.2207751773,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0465315299,0.6037648514,1.8139980168,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.4857091662,1.1189201826,1.9727338563,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0613784423,0.8303994889,1.3566051192,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1042,407,1.6693179961,0.6137705497,4.5401698948,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4596,1734,2.7110095733,1.5266967288,4.8140359299,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4515,3966,1.5882271995,1.1444702285,2.2040465311,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0396769679,0.5996138556,1.8027071715,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.4748570828,1.1105775795,1.958623562,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0541691947,0.8236659136,1.3491789241,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1064,414,5.5556011702,0.720866057,42.816143252,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4682,1773,0.8907438342,0.5523613508,1.4364230535,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4695,4072,1.4422463775,1.0539215013,1.9736523173,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9519322295,0.4774814232,1.8978224608,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1281664489,0.8370566983,1.5205177128,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2927905107,1.0249289484,1.6306567467,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1064,414,5.5606275162,0.7215929553,42.850443797,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4682,1773,0.8912399029,0.5527030945,1.4371342814,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4695,4072,1.440788215,1.0529117471,1.9715523985,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9521402175,0.4775213721,1.8984930243,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1284006268,0.8373736521,1.5205732486,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2903173198,1.022759825,1.6278687774,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1064,414,5.7085758358,0.7401913543,44.02623441,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4682,1773,0.9150782144,0.5663326112,1.4785801167,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4695,4072,1.4963993348,1.0988244633,2.0378240966,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9434979632,0.4726864866,1.8832533438,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1192502447,0.8298299156,1.5096118934,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2798878929,1.0113465169,1.6197346716,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1064,414,5.7293289196,0.7429701127,44.181063687,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4682,1773,0.9172991713,0.5676494573,1.4823193413,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4695,4072,1.4966558264,1.0988921636,2.0383971574,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9426396007,0.4719890785,1.8826058851,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1184279278,0.8292417698,1.5084636053,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2764650464,1.0083485981,1.6158727425,1,1
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0065509104,0.7152082299,1.4165730943,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,2222092.7737,554882.44799,8898634.8598,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4859,4227,8005832.3482,1726625.1378,37120594.496,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0754729E-7,3.3072592E-8,3.4972823E-7,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,2219672.8123,555423.80457,8870608.9895,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4859,17843,2.5432127996,0.494156087,13.088842805,1,0
Kidney disease,Amyloidosis,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.0062884593,1.0062884593,1.0062884593,1,1
Kidney disease,Amyloidosis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4795,1796,2409940.9788,602871.47561,9633588.18,0,0
Kidney disease,Amyloidosis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4859,4227,8672339.131,1872202.0789,40171660.341,0,0
Kidney disease,Amyloidosis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,9.8863027E-8,3.7955385E-8,2.5751018E-7,0,0
Kidney disease,Amyloidosis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,2406536.7813,603542.17524,9595715.9538,0,0
Kidney disease,Amyloidosis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4859,17843,2.5476041727,0.4964543739,13.073279966,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,0.7374199513,0.2481060296,2.1917572315,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4795,1796,2158674.9181,506601.87464,9198302.7214,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4859,4227,4520029.9122,1134086.2531,18015093.96,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,8.4180128E-8,1.8019231E-8,3.9326284E-7,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4795,7897,3276592.8029,832647.20691,12893888.68,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4859,17843,2.6401114348,0.4832788511,14.422705179,1,0
Kidney disease,Amyloidosis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,0.7618860328,0.3417260956,1.6986420833,1,0
Kidney disease,Amyloidosis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4795,1796,2238376.1558,511700.51334,9791523.9177,0,0
Kidney disease,Amyloidosis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4859,4227,5277647.8677,1333256.7648,20891374.979,0,0
Kidney disease,Amyloidosis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,8.4235598E-8,2.1657817E-8,3.276247E-7,0,0
Kidney disease,Amyloidosis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4795,7897,3226826.6652,828874.58176,12562105.965,0,0
Kidney disease,Amyloidosis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4859,17843,2.6452227417,0.4852229553,14.420594237,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,732710.21617,217046.30133,2473501.0806,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1795,219796.61958,96157.541934,502410.45066,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,4853,4219,2.1063498119,0.9002851216,4.9281160196,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1900,5.7087604488,0.5715954104,57.015758469,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2549090632,0.3765446993,4.1822305818,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4853,17833,1.3268779577,0.7538894493,2.3353624546,1,0
Kidney disease,IgA nephropathy,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1082,420,795868.93701,234631.65737,2699581.8552,0,0
Kidney disease,IgA nephropathy,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4792,1795,238041.46085,104122.44371,544202.9121,0,0
Kidney disease,IgA nephropathy,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4853,4219,2.1133815873,0.9032596429,4.9447373949,1,0
Kidney disease,IgA nephropathy,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1900,5.728430077,0.5728104117,57.287560558,1,0
Kidney disease,IgA nephropathy,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2580583449,0.3775378682,4.1921908566,1,0
Kidney disease,IgA nephropathy,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4853,17833,1.3365162294,0.7601425247,2.3499219861,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1082,420,708442.01764,206729.68091,2427760.2043,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4792,1795,214237.53547,92610.512842,495599.47566,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4853,4219,2.0685224894,0.9096058486,4.7039993157,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1082,1900,5.7771811837,0.5792988799,57.61416703,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2697259979,0.3810801471,4.2306168974,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4853,17833,1.3462993105,0.7510497236,2.413318022,1,0
Kidney disease,IgA nephropathy,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1082,420,748683.02809,215633.79807,2599436.0882,0,0
Kidney disease,IgA nephropathy,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4792,1795,226184.98574,97166.125021,526517.32036,0,0
Kidney disease,IgA nephropathy,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4853,4219,2.0285870612,0.8901707828,4.6228943304,1,0
Kidney disease,IgA nephropathy,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1082,1900,5.8462416593,0.5860960206,58.315600753,1,0
Kidney disease,IgA nephropathy,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.282732921,0.3853865542,4.2694892403,1,0
Kidney disease,IgA nephropathy,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4853,17833,1.3660463643,0.7645244112,2.4408411847,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,666879.65376,152754.98328,2911384.382,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4793,1796,0.6013626315,0.0835250632,4.3296826202,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4858,4222,1.3654322499,0.5454162679,3.4183161354,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,663111.82598,153228.2521,2869688.114,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2397096247,0.2215783866,6.9360553507,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4858,17844,1.8407514243,0.9335783313,3.629439215,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,688115.74597,156268.58549,3030060.574,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4793,1796,0.6059627221,0.0839822171,4.3722449006,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4858,4222,1.3692317807,0.5473251878,3.4253780217,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,683734.39388,157011.99438,2977433.1778,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2474002265,0.2228642901,6.9818602353,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4858,17844,1.8484252673,0.9368619465,3.6469364367,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,630550.63035,143170.40636,2777069.0014,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4793,1796,0.5630236888,0.0796725407,3.9787318341,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4858,4222,1.3089763509,0.5311457938,3.2258922266,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,700404.92295,161871.57831,3030594.1366,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2648215577,0.224255483,7.1337099603,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4858,17844,1.8584590059,0.9285591808,3.7196012362,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,652823.67849,146598.60933,2907113.2199,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4793,1796,0.5631496879,0.0805614135,3.9365939235,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4858,4222,1.3116567054,0.5325535422,3.2305546321,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,736651.48513,169310.8874,3205082.7852,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.276803715,0.2255536816,7.2276706594,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4858,17844,1.8677037527,0.9321452109,3.7422466663,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0212146546,0.875010235,1.1918481967,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1795,1.2991183961,0.1429212895,11.808657853,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4841,4188,0.853117945,0.5302643485,1.3725422613,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0082736681,0.9078883134,1.1197586473,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.2169459123,0.3839794882,12.799770116,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4841,17792,1.5482574071,1.0118473264,2.3690342764,1,1
Lung disease,Interstitial lung disease,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.027972943,0.8783810616,1.2030409325,1,0
Lung disease,Interstitial lung disease,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4792,1795,1.2910290464,0.1420335982,11.734941735,1,0
Lung disease,Interstitial lung disease,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4841,4188,0.85170414,0.5291172539,1.3709625546,1,0
Lung disease,Interstitial lung disease,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0099559692,0.9081811158,1.1231361697,1,0
Lung disease,Interstitial lung disease,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.2037117819,0.3817746983,12.7204491,1,0
Lung disease,Interstitial lung disease,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4841,17792,1.5429534341,1.0067456955,2.3647533937,1,1
Lung disease,Interstitial lung disease,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,1.1177772034,0.905508175,1.379806291,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4792,1795,1.5939111752,0.174848076,14.530058854,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4841,4188,1.073147217,0.6866059644,1.6773011146,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0294913509,0.9103346169,1.1642449071,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.0680269533,0.3572302484,11.971929867,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4841,17792,1.4395536233,0.9228695278,2.2455120383,1,0
Lung disease,Interstitial lung disease,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,1.1147402916,0.8940364474,1.3899275822,1,0
Lung disease,Interstitial lung disease,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4792,1795,1.572600595,0.1724293965,14.34252327,1,0
Lung disease,Interstitial lung disease,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4841,4188,1.0619041399,0.6797377034,1.6589346107,1,0
Lung disease,Interstitial lung disease,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0337305505,0.9103802343,1.1737939938,1,0
Lung disease,Interstitial lung disease,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.0617748165,0.3559233162,11.943346224,1,0
Lung disease,Interstitial lung disease,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4841,17792,1.4403797591,0.9206453944,2.2535211311,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,419,38016.577875,14700.748494,98312.014105,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4769,1780,1.3516064517,0.6692558539,2.7296586045,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,4737,4088,1.0436755381,0.8334220448,1.3069712225,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0184395957,0.3670676276,2.8256896874,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.0358348314,0.6609708669,1.6232996818,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4737,17629,0.9951187796,0.8326754965,1.1892524635,1,0
Lung disease,Restrictive lung disease ,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1080,419,43481.714638,16748.744506,112883.65568,0,0
Lung disease,Restrictive lung disease ,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4769,1780,1.3466536337,0.6673365369,2.7174834719,1,0
Lung disease,Restrictive lung disease ,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4737,4088,1.0409175431,0.8310327285,1.3038106618,1,0
Lung disease,Restrictive lung disease ,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0170214101,0.3656602115,2.8286713076,1,0
Lung disease,Restrictive lung disease ,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.0331644726,0.6600481995,1.6171983018,1,0
Lung disease,Restrictive lung disease ,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4737,17629,0.9899108612,0.8276980437,1.1839142554,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1080,419,39585.967911,15355.711692,102049.90083,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4769,1780,1.4103599632,0.6993011617,2.8444328921,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4737,4088,1.0987547127,0.8826780143,1.3677262822,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0039662475,0.3611942637,2.7905986538,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.0240186649,0.6529171376,1.6060448801,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4737,17629,0.9786307931,0.8152250506,1.1747899903,1,0
Lung disease,Restrictive lung disease ,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1080,419,45326.888715,17564.803593,116968.39248,0,0
Lung disease,Restrictive lung disease ,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4769,1780,1.4057130239,0.6984946475,2.8289824593,1,0
Lung disease,Restrictive lung disease ,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4737,4088,1.0976781325,0.8816823178,1.3665889156,1,0
Lung disease,Restrictive lung disease ,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0031907675,0.359591328,2.79870964,1,0
Lung disease,Restrictive lung disease ,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.022125364,0.6521674713,1.6019508878,1,0
Lung disease,Restrictive lung disease ,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4737,17629,0.9716018024,0.8079306766,1.1684295322,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0224087859,0.8385627712,1.2465610939,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.8514680506,0.0776158639,9.3408461221,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4861,4224,15.917053751,1.8667440144,135.71898352,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,1.7638757E-6,2.4670592E-7,0.0000126112,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7896,575803.36759,144882.18855,2288407.7155,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4861,17837,2.5232400768,0.9781171103,6.5091801566,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.0285464055,0.8498296791,1.2448467432,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.8457889486,0.0774394873,9.2376508513,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4861,4224,15.843335219,1.8561485438,135.23231839,1,1
Neurological Disease,Cauda Equina syndrome,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,1.5799257E-6,2.2119272E-7,0.000011285,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7896,640366.93844,161965.54204,2531833.6893,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4861,17837,2.5001651175,0.9625734907,6.4938684421,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,0.9464228723,0.7066086582,1.2676270561,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4795,1796,0.7977064975,0.0723414621,8.7962786221,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4861,4224,14.329097735,1.6881328766,121.62729886,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1899,1.7442085E-6,2.4491832E-7,0.0000124215,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4795,7896,600767.00508,149908.11215,2407614.833,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4861,17837,2.5930199502,0.9856955214,6.8213280027,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,0.9479567058,0.7366674066,1.2198475296,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4795,1796,0.7892114592,0.0720448958,8.6453692644,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4861,4224,14.224081223,1.6744269893,120.83207446,1,1
Neurological Disease,Cauda Equina syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1899,5.7513441E-7,8.1312376E-8,4.0680103E-6,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4795,7896,1819924.6421,454875.76159,7281385.3422,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4861,17837,2.5727559204,0.9704715786,6.8204707606,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0001725425,0.860342339,1.1627291479,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1794,0.7354734639,0.1978447449,2.7340691632,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,4846,4208,0.587394735,0.326216854,1.0576785672,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,5.6593056E-6,1.3920847E-6,0.000023007,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6995534014,0.3308638884,1.479082422,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4846,17805,0.4848414544,0.3084497825,0.7621053709,1,1
Neurological Disease,Spinal Cord compression,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1083,421,1.001002575,0.8568060461,1.1694667187,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4792,1794,0.724364044,0.194555583,2.6969324652,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4846,4208,0.5812284853,0.3224349518,1.0477355209,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,1.761851E-6,4.3342095E-7,7.1619035E-6,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6899781225,0.3261015659,1.4598820103,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4846,17805,0.4755275371,0.3014424742,0.7501478983,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1083,421,0.989792286,0.8312179115,1.1786184536,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4792,1794,0.7717404159,0.2082379825,2.8601087199,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4846,4208,0.6373543209,0.3526781197,1.1518166499,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1083,1899,5.470572E-6,1.3425589E-6,0.0000222911,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6955950318,0.3282480085,1.4740453432,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4846,17805,0.477417899,0.3025306021,0.7534042794,1,1
Neurological Disease,Spinal Cord compression,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1083,421,0.9853146333,0.8198943423,1.1841098011,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4792,1794,0.7595164799,0.2052167092,2.8110054263,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4846,4208,0.6259577088,0.3453046103,1.1347171206,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1083,1899,1.706751E-6,4.1878114E-7,6.9558983E-6,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6870618973,0.3235728094,1.4588804656,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4846,17805,0.4700642443,0.29689971,0.7442256976,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1079,420,1.8800201886,0.234710086,15.058900833,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4777,1792,1.1038357538,0.483092427,2.5221951399,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4741,4088,0.9582626533,0.7566556871,1.2135867454,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8445238147,0.3604292082,1.9788087572,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.5067677598,0.2962162931,0.866979867,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6863492694,0.5695481692,0.8271035622,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1079,420,1.8648735209,0.2325490561,14.954923091,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4777,1792,1.0960485844,0.4798236852,2.503674863,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4741,4088,0.9525930465,0.7517798559,1.2070468569,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8420470113,0.3590939552,1.9745338486,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.503912353,0.2947839416,0.8614026199,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6793057413,0.5630614418,0.8195487311,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1079,420,1.9403830708,0.2422585231,15.541605771,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4777,1792,1.1456999748,0.5014969125,2.6174207646,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4741,4088,1.0129153662,0.8039239957,1.2762369882,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8352076004,0.3565171324,1.9566289312,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.5020308542,0.2931519464,0.859741788,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6736738525,0.5568229359,0.8150462748,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1079,420,1.9172709233,0.2391907668,15.368184329,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4777,1792,1.1319374542,0.496148438,2.5824577931,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4741,4088,0.9990666981,0.7925114818,1.2594571689,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8333433317,0.3554431067,1.9537897783,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.4995219096,0.2917220961,0.8553419214,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6681894793,0.5514126807,0.8096969763,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1073,416,1.2342609007,0.3652814361,4.1704828675,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4758,1782,1.247425085,0.7307802676,2.1293258884,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4692,4050,0.97181046,0.7968083831,1.1852480347,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1073,1884,0.615987916,0.3168074469,1.1977026311,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0503557648,0.7614876894,1.4488050797,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9364142959,0.7954779144,1.1023206524,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1073,416,1.2294291872,0.3640529648,4.1518577591,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4758,1782,1.2432336339,0.7281379638,2.1227156741,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4692,4050,0.9709368696,0.7960896749,1.1841861973,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1073,1884,0.6147112899,0.316160443,1.1951842122,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0471061004,0.7590278535,1.4445203566,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9336926335,0.7929962561,1.0993518912,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1073,416,1.2965026569,0.3841937433,4.3751861361,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4758,1782,1.3055954669,0.7636761808,2.2320710872,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4692,4050,1.0264837267,0.8458626862,1.2456736282,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1073,1884,0.6056245654,0.3110205959,1.1792823981,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0351536988,0.7501983794,1.4283464343,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9170808496,0.7762922441,1.0834029209,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1073,416,1.2908979023,0.3832367711,4.3482711474,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4758,1782,1.2997667963,0.7598054877,2.2234555453,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4692,4050,1.0223955753,0.8424969527,1.2407080038,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1073,1884,0.6044710499,0.3102472243,1.1777228659,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0321753226,0.7478467689,1.4246045325,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4692,17452,0.914925489,0.7740642654,1.0814200938,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1062,416,2.412193905,0.6602253751,8.8131714638,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4664,1756,1.3499644091,0.8723090572,2.0891722845,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4590,4034,1.1108548418,0.8779548888,1.4055374545,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6482992547,0.9495737291,2.8611684904,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6635064536,1.2781466556,2.1650518029,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3740813375,1.1426754398,1.6523497894,1,1
PsO/PsA,Psoriasis,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1062,416,2.3975347927,0.6560384506,8.7619453963,1,0
PsO/PsA,Psoriasis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4664,1756,1.343291743,0.8680627252,2.0786893096,1,0
PsO/PsA,Psoriasis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4590,4034,1.1092662933,0.8765864702,1.4037083063,1,0
PsO/PsA,Psoriasis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6412196951,0.9452380269,2.8496548075,1,0
PsO/PsA,Psoriasis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6559736414,1.2724849997,2.1550342059,1,1
PsO/PsA,Psoriasis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3710811246,1.1398203539,1.6492629245,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1062,416,2.383705573,0.6511675153,8.7259455134,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4664,1756,1.3379786257,0.8647754818,2.0701174356,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4590,4034,1.1036233985,0.876471623,1.3896452251,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6553882427,0.9537826916,2.8730970464,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6699014641,1.2816808287,2.1757139823,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3786962737,1.1418028873,1.6647386657,1,1
PsO/PsA,Psoriasis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1062,416,2.35814983,0.6435636427,8.6407470092,1,0
PsO/PsA,Psoriasis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4664,1756,1.3263665604,0.85788282,2.0506859581,1,0
PsO/PsA,Psoriasis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4590,4034,1.0982188541,0.8718679153,1.3833341385,1,0
PsO/PsA,Psoriasis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6507057871,0.9509789323,2.8652891281,1,0
PsO/PsA,Psoriasis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6646113376,1.2772708363,2.1694153082,1,1
PsO/PsA,Psoriasis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3779416273,1.1410148748,1.6640651847,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1038,403,1.290862162,0.5397966383,3.0869497936,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4550,1727,0.7693487183,0.5468026772,1.0824699203,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4405,3940,1.2902240349,1.0024557311,1.6606000728,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1882,1.8160910426,1.0426264996,3.1633443772,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0197703558,1.5370012488,2.6541763017,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4405,17533,1.922211533,1.5733657555,2.3484032016,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1038,403,1.2828018414,0.5363438266,3.0681448778,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4550,1727,0.7650087406,0.5435829132,1.0766312901,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4405,3940,1.2868165773,0.9995340208,1.6566688767,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1882,1.8087591887,1.0383216621,3.1508634774,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0103967208,1.5295866514,2.642344565,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4405,17533,1.9146686085,1.5661390982,2.3407600799,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1038,403,1.3305499652,0.5564108616,3.1817553037,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4550,1727,0.7905319846,0.5625524767,1.1109022616,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4405,3940,1.3277649958,1.0369490722,1.7001412426,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1038,1882,1.7976195609,1.0315701392,3.1325413203,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0031586682,1.5222006568,2.6360812762,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4405,17533,1.9035901354,1.5517715815,2.3351731961,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1038,403,1.3163528016,0.5505616764,3.1473035128,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4550,1727,0.7831091249,0.5578838417,1.0992609137,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4405,3940,1.3186069576,1.0289180133,1.6898570014,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1038,1882,1.7933168642,1.0288676827,3.1257521542,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4550,7808,1.9966801098,1.5162789151,2.6292863542,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4405,17533,1.8989056197,1.5473374129,2.33035311,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1020,394,0.8751286874,0.4508601747,1.6986424226,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4489,1703,1.2925347701,0.9223039445,1.8113834834,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4542,3998,1.3888082673,1.090745039,1.7683219581,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8077960449,0.5238041821,1.2457602907,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8708813281,0.7172829544,1.0573711295,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4542,17547,1.2092235629,1.0170090123,1.4377666346,1,1
Uveitis,Uveitis,"b Weighted, stabilized, no covariates",TNF vs DMARD,MPCD,1020,394,0.8729595769,0.449762349,1.6943579749,1,0
Uveitis,Uveitis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Marketscan,4489,1703,1.2900320828,0.9205795995,1.8077554354,1,0
Uveitis,Uveitis,"b Weighted, stabilized, no covariates",TNF vs DMARD,Medicare,4542,3998,1.385117684,1.0875914724,1.7640364486,1,1
Uveitis,Uveitis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8068756722,0.5232508391,1.244237566,1,0
Uveitis,Uveitis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8694118311,0.7161072154,1.0555359809,1,0
Uveitis,Uveitis,"b Weighted, stabilized, no covariates",TNF vs NSAID or no exposure,Medicare,4542,17547,1.2030860632,1.0112076193,1.431373783,1,1
Uveitis,Uveitis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,MPCD,1020,394,0.8711755904,0.4488713168,1.6907895001,1,0
Uveitis,Uveitis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Marketscan,4489,1703,1.2867719053,0.918330781,1.803034343,1,0
Uveitis,Uveitis,"c Weighted, covariates (6-month daily ste",TNF vs DMARD,Medicare,4542,3998,1.3847549686,1.0889631348,1.7608918629,1,1
Uveitis,Uveitis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8080524378,0.5237672929,1.2466390152,1,0
Uveitis,Uveitis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8712942818,0.7169342972,1.0588888388,1,0
Uveitis,Uveitis,"c Weighted, covariates (6-month daily ste",TNF vs NSAID or no exposure,Medicare,4542,17547,1.2063785351,1.0128610285,1.4368695498,1,1
Uveitis,Uveitis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,MPCD,1020,394,0.8733606905,0.4501621716,1.6944091349,1,0
Uveitis,Uveitis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Marketscan,4489,1703,1.2895529163,0.92090627,1.8057719642,1,0
Uveitis,Uveitis,"d Weighted, stabilized, covariates (6-mon",TNF vs DMARD,Medicare,4542,3998,1.3852683667,1.0889106117,1.7622828054,1,1
Uveitis,Uveitis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8059159878,0.5223631531,1.2433889632,1,0
Uveitis,Uveitis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8686980708,0.7145555334,1.0560919383,1,0
Uveitis,Uveitis,"d Weighted, stabilized, covariates (6-mon",TNF vs NSAID or no exposure,Medicare,4542,17547,1.1988592331,1.0058662781,1.4288812461,1,1
